Cargando…

Exploration of metformin as novel therapy for osteoarthritis: preventing cartilage degeneration and reducing pain behavior

BACKGROUND: Metformin could activate adenosine monophosphate-activated protein kinase (AMPK) which was postulated as a potential therapeutic target for osteoarthritis. This study aimed to examine the effects of metformin on cartilage and pain in osteoarthritis mouse model. METHODS: Eighty 10-week-ol...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hui, Ding, Xiang, Terkeltaub, Robert, Lin, Hang, Zhang, Yuqing, Zhou, Bin, He, Ke, Li, Kun, Liu, Zhichen, Wei, Jie, Yang, Yuanheng, Xie, Hui, Zeng, Chao, Lei, Guanghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036179/
https://www.ncbi.nlm.nih.gov/pubmed/32087740
http://dx.doi.org/10.1186/s13075-020-2129-y
_version_ 1783500171735203840
author Li, Hui
Ding, Xiang
Terkeltaub, Robert
Lin, Hang
Zhang, Yuqing
Zhou, Bin
He, Ke
Li, Kun
Liu, Zhichen
Wei, Jie
Yang, Yuanheng
Xie, Hui
Zeng, Chao
Lei, Guanghua
author_facet Li, Hui
Ding, Xiang
Terkeltaub, Robert
Lin, Hang
Zhang, Yuqing
Zhou, Bin
He, Ke
Li, Kun
Liu, Zhichen
Wei, Jie
Yang, Yuanheng
Xie, Hui
Zeng, Chao
Lei, Guanghua
author_sort Li, Hui
collection PubMed
description BACKGROUND: Metformin could activate adenosine monophosphate-activated protein kinase (AMPK) which was postulated as a potential therapeutic target for osteoarthritis. This study aimed to examine the effects of metformin on cartilage and pain in osteoarthritis mouse model. METHODS: Eighty 10-week-old male C57BL/6 mice were randomized to 6 groups: non-operation, sham-operation, destabilization of the medial meniscus (DMM)-operation with intragastric saline/metformin, and DMM-operation with intraarticular saline/metformin. Articular cartilage degeneration was examined by scanning electron microscopy (SEM) and graded using the scoring system recommended by Osteoarthritis Research Society International (OARSI). Mechanical withdrawal threshold and hind paw weight distribution were measured to assess the pain-related behavior. Cell Counting Kit-8 assay, quantificational real-time polymerase chain reaction, and western blot analysis were conducted to examine the anabolic and anti-catabolic effect of metformin and the role of AMPK in mediating its effects on interleukin-1β stimulated primary mice chondrocytes. RESULTS: Compared with mice receiving intragastric and intraarticular saline, mice in both intragastric and intraarticular metformin displayed attenuated articular cartilage degeneration, indicated by less cartilage damage under SEM and significantly lower OARSI scores. A higher paw withdrawal threshold and a decreased weight-bearing asymmetry were observed in the intragastric and intraarticular metformin mice compared with their corresponding saline groups in DMM model of osteoarthritis. In vitro experiments showed that metformin not only decreased the level of matrix metalloproteinase 13, but also elevated type II collagen production through activating AMPK pathway. CONCLUSIONS: Metformin attenuates osteoarthritis structural worsening and modulates pain, suggesting its potential for osteoarthritis prevention or treatment.
format Online
Article
Text
id pubmed-7036179
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-70361792020-03-02 Exploration of metformin as novel therapy for osteoarthritis: preventing cartilage degeneration and reducing pain behavior Li, Hui Ding, Xiang Terkeltaub, Robert Lin, Hang Zhang, Yuqing Zhou, Bin He, Ke Li, Kun Liu, Zhichen Wei, Jie Yang, Yuanheng Xie, Hui Zeng, Chao Lei, Guanghua Arthritis Res Ther Research Article BACKGROUND: Metformin could activate adenosine monophosphate-activated protein kinase (AMPK) which was postulated as a potential therapeutic target for osteoarthritis. This study aimed to examine the effects of metformin on cartilage and pain in osteoarthritis mouse model. METHODS: Eighty 10-week-old male C57BL/6 mice were randomized to 6 groups: non-operation, sham-operation, destabilization of the medial meniscus (DMM)-operation with intragastric saline/metformin, and DMM-operation with intraarticular saline/metformin. Articular cartilage degeneration was examined by scanning electron microscopy (SEM) and graded using the scoring system recommended by Osteoarthritis Research Society International (OARSI). Mechanical withdrawal threshold and hind paw weight distribution were measured to assess the pain-related behavior. Cell Counting Kit-8 assay, quantificational real-time polymerase chain reaction, and western blot analysis were conducted to examine the anabolic and anti-catabolic effect of metformin and the role of AMPK in mediating its effects on interleukin-1β stimulated primary mice chondrocytes. RESULTS: Compared with mice receiving intragastric and intraarticular saline, mice in both intragastric and intraarticular metformin displayed attenuated articular cartilage degeneration, indicated by less cartilage damage under SEM and significantly lower OARSI scores. A higher paw withdrawal threshold and a decreased weight-bearing asymmetry were observed in the intragastric and intraarticular metformin mice compared with their corresponding saline groups in DMM model of osteoarthritis. In vitro experiments showed that metformin not only decreased the level of matrix metalloproteinase 13, but also elevated type II collagen production through activating AMPK pathway. CONCLUSIONS: Metformin attenuates osteoarthritis structural worsening and modulates pain, suggesting its potential for osteoarthritis prevention or treatment. BioMed Central 2020-02-22 2020 /pmc/articles/PMC7036179/ /pubmed/32087740 http://dx.doi.org/10.1186/s13075-020-2129-y Text en © The Author(s). 2020 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Li, Hui
Ding, Xiang
Terkeltaub, Robert
Lin, Hang
Zhang, Yuqing
Zhou, Bin
He, Ke
Li, Kun
Liu, Zhichen
Wei, Jie
Yang, Yuanheng
Xie, Hui
Zeng, Chao
Lei, Guanghua
Exploration of metformin as novel therapy for osteoarthritis: preventing cartilage degeneration and reducing pain behavior
title Exploration of metformin as novel therapy for osteoarthritis: preventing cartilage degeneration and reducing pain behavior
title_full Exploration of metformin as novel therapy for osteoarthritis: preventing cartilage degeneration and reducing pain behavior
title_fullStr Exploration of metformin as novel therapy for osteoarthritis: preventing cartilage degeneration and reducing pain behavior
title_full_unstemmed Exploration of metformin as novel therapy for osteoarthritis: preventing cartilage degeneration and reducing pain behavior
title_short Exploration of metformin as novel therapy for osteoarthritis: preventing cartilage degeneration and reducing pain behavior
title_sort exploration of metformin as novel therapy for osteoarthritis: preventing cartilage degeneration and reducing pain behavior
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036179/
https://www.ncbi.nlm.nih.gov/pubmed/32087740
http://dx.doi.org/10.1186/s13075-020-2129-y
work_keys_str_mv AT lihui explorationofmetforminasnoveltherapyforosteoarthritispreventingcartilagedegenerationandreducingpainbehavior
AT dingxiang explorationofmetforminasnoveltherapyforosteoarthritispreventingcartilagedegenerationandreducingpainbehavior
AT terkeltaubrobert explorationofmetforminasnoveltherapyforosteoarthritispreventingcartilagedegenerationandreducingpainbehavior
AT linhang explorationofmetforminasnoveltherapyforosteoarthritispreventingcartilagedegenerationandreducingpainbehavior
AT zhangyuqing explorationofmetforminasnoveltherapyforosteoarthritispreventingcartilagedegenerationandreducingpainbehavior
AT zhoubin explorationofmetforminasnoveltherapyforosteoarthritispreventingcartilagedegenerationandreducingpainbehavior
AT heke explorationofmetforminasnoveltherapyforosteoarthritispreventingcartilagedegenerationandreducingpainbehavior
AT likun explorationofmetforminasnoveltherapyforosteoarthritispreventingcartilagedegenerationandreducingpainbehavior
AT liuzhichen explorationofmetforminasnoveltherapyforosteoarthritispreventingcartilagedegenerationandreducingpainbehavior
AT weijie explorationofmetforminasnoveltherapyforosteoarthritispreventingcartilagedegenerationandreducingpainbehavior
AT yangyuanheng explorationofmetforminasnoveltherapyforosteoarthritispreventingcartilagedegenerationandreducingpainbehavior
AT xiehui explorationofmetforminasnoveltherapyforosteoarthritispreventingcartilagedegenerationandreducingpainbehavior
AT zengchao explorationofmetforminasnoveltherapyforosteoarthritispreventingcartilagedegenerationandreducingpainbehavior
AT leiguanghua explorationofmetforminasnoveltherapyforosteoarthritispreventingcartilagedegenerationandreducingpainbehavior